TrialTechnology in cancer research & treatment

Cytoreductive Surgery (CRS) Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Platinum-Sensitive Recurrence Epithelial Ovarian Cancer With HRR Mutation: A Phase III Randomized Clinical Trial.

Yuwen Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.